.
MergerLinks Header Logo

New Deal


Announced

Completed

One Rock Capital-backed Kensing completed the acquisition of Hopewell, VA amphoteric surfactants and specialty esters operations of Evonik.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Specialty Chemicals

Friendly

Acquisition

amphoteric surfactants

Single Bidder

United States

betaines chemistry

Private Equity

Domestic

Private

specialty esters

Majority

Completed

Synopsis

Edit

One Rock Capital-backed Kensing, a manufacturer of natural vitamin E, plant sterols, specialty esters and high-purity anionic surfactants, completed the acquisition of the Hopewell, VA amphoteric surfactants and specialty esters operations of Evonik, a stock-listed German specialty chemicals company. Financial terms were not disclosed. "This transaction expands our existing surfactant and specialty esters product offerings and we're pleased to officially welcome our colleagues at the Hopewell site into the Kensing family. This transaction marks our second add-on acquisition since becoming a standalone company in June 2021. We look forward to building on this momentum by actively pursuing additional strategic opportunities aimed at providing our customers with an expanded range of high quality, plant-based products and strengthening our leading position in our core markets." Serge Rogasik, Kensing CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US